New virtual research centres to break new ground in cystic fibrosis science and care

The development of new drugs to treat the most common cause of cystic fibrosis, a genetic defect (or mutation) carried by around 90 per cent of people living with the disease in the UK, will be helped by the creation of a new virtual Strategic Research Centre (SRC) led by the University of Bristol.
Source: University of Bristol news - Category: Universities & Medical Training Tags: Grants and Awards, Research; Institutes, Elizabeth Blackwell, Faculty of Medical and Veterinary Sciences, School of Physiology and Pharmacology, Faculty of Medical and Veterinary Sciences; Press Release Source Type: news